ORION GROUP HOLDINGS INC (ORN)

US68628V3087 - Common Stock

7.7  -0.06 (-0.77%)

After market: 7.7 0 (0%)

Fundamental Rating

3

ORN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 44 industry peers in the Construction & Engineering industry. While ORN seems to be doing ok healthwise, there are quite some concerns on its profitability. ORN is not valued too expensively and it also shows a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year ORN has reported negative net income.
In the past year ORN had a positive cash flow from operations.
ORN had negative earnings in 4 of the past 5 years.
ORN had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

ORN has a Return On Assets of -2.97%. This is in the lower half of the industry: ORN underperforms 76.19% of its industry peers.
The Return On Equity of ORN (-8.96%) is worse than 71.43% of its industry peers.
The Return On Invested Capital of ORN (2.02%) is worse than 69.05% of its industry peers.
Industry RankSector Rank
ROA -2.97%
ROE -8.96%
ROIC 2.02%
ROA(3y)-3.96%
ROA(5y)-1.67%
ROE(3y)-11.24%
ROE(5y)-4.99%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin of ORN (0.73%) is worse than 69.05% of its industry peers.
The Gross Margin of ORN (10.73%) is worse than 73.81% of its industry peers.
In the last couple of years the Gross Margin of ORN has grown nicely.
Industry RankSector Rank
OM 0.73%
PM (TTM) N/A
GM 10.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y21.85%

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ORN is destroying value.
ORN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ORN has more shares outstanding
ORN has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.46 indicates that ORN is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ORN (2.46) is comparable to the rest of the industry.
ORN has a debt to FCF ratio of 1.56. This is a very positive value and a sign of high solvency as it would only need 1.56 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.56, ORN belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
A Debt/Equity ratio of 0.24 indicates that ORN is not too dependend on debt financing.
The Debt to Equity ratio of ORN (0.24) is better than 73.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.56
Altman-Z 2.46
ROIC/WACC0.14
WACC14.49%

2.3 Liquidity

A Current Ratio of 1.35 indicates that ORN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.35, ORN perfoms like the industry average, outperforming 45.24% of the companies in the same industry.
ORN has a Quick Ratio of 1.33. This is a normal value and indicates that ORN is financially healthy and should not expect problems in meeting its short term obligations.
ORN has a Quick ratio (1.33) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.33

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 92.86% over the past year.
Looking at the last year, ORN shows a quite strong growth in Revenue. The Revenue has grown by 10.58% in the last year.
The Revenue has been growing slightly by 6.44% on average over the past years.
EPS 1Y (TTM)92.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
Revenue 1Y (TTM)10.58%
Revenue growth 3Y0.09%
Revenue growth 5Y6.44%
Sales Q2Q%34.54%

3.2 Future

ORN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.65% yearly.
ORN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.50% yearly.
EPS Next Y126.65%
EPS Next 2Y68.02%
EPS Next 3Y53.65%
EPS Next 5YN/A
Revenue Next Year21.42%
Revenue Next 2Y11.28%
Revenue Next 3Y10.94%
Revenue Next 5Y5.5%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

5

4. Valuation

4.1 Price/Earnings Ratio

ORN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 25.99, the valuation of ORN can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ORN is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of ORN to the average of the S&P500 Index (23.67), we can say ORN is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 25.99

4.2 Price Multiples

ORN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ORN is cheaper than 85.71% of the companies in the same industry.
ORN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ORN is cheaper than 88.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.33
EV/EBITDA 10.71

4.3 Compensation for Growth

ORN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ORN's earnings are expected to grow with 53.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y68.02%
EPS Next 3Y53.65%

0

5. Dividend

5.1 Amount

ORN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ORION GROUP HOLDINGS INC

NYSE:ORN (1/6/2025, 7:00:00 PM)

After market: 7.7 0 (0%)

7.7

-0.06 (-0.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)N/A N/A
Inst Owners69.22%
Inst Owner Change0%
Ins Owners6.54%
Ins Owner Change-0.56%
Market Cap299.53M
Analysts80
Price Target11.56 (50.13%)
Short Float %1.99%
Short Ratio1.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-673.27%
Min EPS beat(2)-1484.16%
Max EPS beat(2)137.61%
EPS beat(4)3
Avg EPS beat(4)-306.78%
Min EPS beat(4)-1484.16%
Max EPS beat(4)137.61%
EPS beat(8)4
Avg EPS beat(8)-759.48%
EPS beat(12)7
Avg EPS beat(12)-494.42%
EPS beat(16)9
Avg EPS beat(16)-370.76%
Revenue beat(2)0
Avg Revenue beat(2)-2.93%
Min Revenue beat(2)-4.55%
Max Revenue beat(2)-1.31%
Revenue beat(4)1
Avg Revenue beat(4)-2.62%
Min Revenue beat(4)-8.97%
Max Revenue beat(4)4.33%
Revenue beat(8)3
Avg Revenue beat(8)-2.26%
Revenue beat(12)7
Avg Revenue beat(12)3.13%
Revenue beat(16)8
Avg Revenue beat(16)1.17%
PT rev (1m)0%
PT rev (3m)6.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-32.08%
EPS NY rev (1m)0%
EPS NY rev (3m)35.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.99
P/S 0.38
P/FCF 9.33
P/OCF 6.66
P/B 2.1
P/tB 2.1
EV/EBITDA 10.71
EPS(TTM)-0.04
EYN/A
EPS(NY)0.3
Fwd EY3.85%
FCF(TTM)0.83
FCFY10.72%
OCF(TTM)1.16
OCFY15.02%
SpS20.08
BVpS3.66
TBVpS3.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.97%
ROE -8.96%
ROCE 2.56%
ROIC 2.02%
ROICexc 2.32%
ROICexgc 2.32%
OM 0.73%
PM (TTM) N/A
GM 10.73%
FCFM 4.11%
ROA(3y)-3.96%
ROA(5y)-1.67%
ROE(3y)-11.24%
ROE(5y)-4.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y21.85%
F-Score5
Asset Turnover1.82
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.56
Debt/EBITDA 1.14
Cap/Depr 52.42%
Cap/Sales 1.65%
Interest Coverage 0.77
Cash Conversion 148.87%
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 1.33
Altman-Z 2.46
F-Score5
WACC14.49%
ROIC/WACC0.14
Cap/Depr(3y)54.89%
Cap/Depr(5y)55.84%
Cap/Sales(3y)2.01%
Cap/Sales(5y)2.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
EPS Next Y126.65%
EPS Next 2Y68.02%
EPS Next 3Y53.65%
EPS Next 5YN/A
Revenue 1Y (TTM)10.58%
Revenue growth 3Y0.09%
Revenue growth 5Y6.44%
Sales Q2Q%34.54%
Revenue Next Year21.42%
Revenue Next 2Y11.28%
Revenue Next 3Y10.94%
Revenue Next 5Y5.5%
EBIT growth 1Y131.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year829.58%
EBIT Next 3Y133.07%
EBIT Next 5YN/A
FCF growth 1Y389.61%
FCF growth 3Y-35.86%
FCF growth 5Y14.4%
OCF growth 1Y812.6%
OCF growth 3Y-28%
OCF growth 5Y-4.77%